Marko Ogorevc - Search Results

Year	Number of Results
2011	1
2014	1
2017	2
2019	1
2020	2
2021	3
2022	2
2023	2
2024	0

1

Prevolnik Rupel V, Ogorevc M. Prevolnik Rupel V, et al. Among authors: ogorevc m. Pharmacoeconomics. 2023 Nov;41(11):1515-1524. doi: 10.1007/s40273-023-01280-9. Epub 2023 Jun 21. Pharmacoeconomics. 2023. PMID: 37341959 Free PMC article.

2

EQ-5D-Y Value Set for Slovenia.

Prevolnik Rupel V, Ogorevc M; IMPACT HTA HRQoL Group. Prevolnik Rupel V, et al. Among authors: ogorevc m. Pharmacoeconomics. 2021 Apr;39(4):463-471. doi: 10.1007/s40273-020-00994-4. Epub 2021 Feb 10. Pharmacoeconomics. 2021. PMID: 33565048 Free PMC article.

3

EQ-5D-5L Slovenian population norms.

Prevolnik Rupel V, Ogorevc M. Prevolnik Rupel V, et al. Among authors: ogorevc m. Health Qual Life Outcomes. 2020 Oct 7;18(1):333. doi: 10.1186/s12955-020-01584-w. Health Qual Life Outcomes. 2020. PMID: 33028345 Free PMC article.

4

Crosswalk EQ-5D-5L Value Set for Slovenia.

Prevolnik Rupel V, Ogorevc M. Prevolnik Rupel V, et al. Among authors: ogorevc m. Zdr Varst. 2020 Jun 25;59(3):189-194. doi: 10.2478/sjph-2020-0024. eCollection 2020 Sep. Zdr Varst. 2020. PMID: 32952720 Free PMC article.

5

Comparison of Adult and Adolescent Preferences Toward EQ-5D-Y-3L Health States.

Prevolnik Rupel V, Ramos-Goñi JM, Ogorevc M, Kreimeier S, Ludwig K, Greiner W. Prevolnik Rupel V, et al. Among authors: ogorevc m. Value Health. 2021 Sep;24(9):1350-1359. doi: 10.1016/j.jval.2021.03.019. Epub 2021 Jun 25. Value Health. 2021. PMID: 34452716 Free PMC article.

6

Costs and Quality of Life in Patients With Systemic Arterial Hypertension in Slovenia.

Prevolnik Rupel V, Mori Lukančič M, Ogorevc M. Prevolnik Rupel V, et al. Among authors: ogorevc m. Value Health Reg Issues. 2023 Jan;33:49-55. doi: 10.1016/j.vhri.2022.09.001. Epub 2022 Oct 12. Value Health Reg Issues. 2023. PMID: 36242818

7

Improving the Methods for the Economic Evaluation of Medical Devices.

Tarricone R, Callea G, Ogorevc M, Prevolnik Rupel V. Tarricone R, et al. Among authors: ogorevc m. Health Econ. 2017 Feb;26 Suppl 1:70-92. doi: 10.1002/hec.3471. Health Econ. 2017. PMID: 28139085

8

Predicting Patient-Level 3-Level Version of EQ-5D Index Scores From a Large International Database Using Machine Learning and Regression Methods.

Zrubka Z, Csabai I, Hermann Z, Golicki D, Prevolnik-Rupel V, Ogorevc M, Gulácsi L, Péntek M. Zrubka Z, et al. Among authors: ogorevc m. Value Health. 2022 Sep;25(9):1590-1601. doi: 10.1016/j.jval.2022.01.024. Epub 2022 Mar 15. Value Health. 2022. PMID: 35300933 Free article.

9

Payments for Conservation of Animal Genetic Resources in Agriculture: One Size Fits All?

Juvančič L, Slabe-Erker R, Ogorevc M, Drucker AG, Erjavec E, Bojkovski D. Juvančič L, et al. Among authors: ogorevc m. Animals (Basel). 2021 Mar 17;11(3):846. doi: 10.3390/ani11030846. Animals (Basel). 2021. PMID: 33802686 Free PMC article.

10

Questioning the differences between general public vs. patient based preferences towards EQ-5D-5L defined hypothetical health states.

Ogorevc M, Murovec N, Fernandez NB, Rupel VP. Ogorevc M, et al. Health Policy. 2019 Feb;123(2):166-172. doi: 10.1016/j.healthpol.2017.03.011. Epub 2017 Mar 28. Health Policy. 2019. PMID: 28410808

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

12 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

12 results

Results by year